These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1267 related items for PubMed ID: 18927282

  • 1. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282
    [Abstract] [Full Text] [Related]

  • 2. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S.
    Clin Cancer Res; 2005 Nov 01; 11(21):7674-82. PubMed ID: 16278387
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 5. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q, Zhao XY, Bai RZ, Liang SF, Nie CL, Yuan Z, Wang CT, Wu Y, Chen LJ, Wei YQ.
    Oncol Rep; 2009 Nov 04; 22(5):1069-75. PubMed ID: 19787223
    [Abstract] [Full Text] [Related]

  • 6. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 04; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 7. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH, Lai WW, Chen HH, Liu HS, Su WC.
    Oncogene; 2006 Jul 20; 25(31):4300-9. PubMed ID: 16518408
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
    Yin ZJ, Jin FG, Liu TG, Fu EQ, Xie YH, Sun RL.
    J Surg Res; 2011 Dec 20; 171(2):675-83. PubMed ID: 20605584
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.
    Eur J Cancer; 2011 Oct 15; 47(15):2353-63. PubMed ID: 21680174
    [Abstract] [Full Text] [Related]

  • 11. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
    Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A.
    J Natl Cancer Inst; 2009 Feb 18; 101(4):237-47. PubMed ID: 19211441
    [Abstract] [Full Text] [Related]

  • 12. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J, Xu YJ, Zhang ZX, DU CL, Qiao LF, Ni W, Chen SX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct 18; 30(10):771-5. PubMed ID: 18218209
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R, Xiong S.
    Clin Cancer Res; 2005 Dec 01; 11(23):8273-80. PubMed ID: 16322285
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM, Webster SJ, Flower D, Woll PJ.
    Br J Cancer; 2004 Nov 29; 91(11):1970-6. PubMed ID: 15545974
    [Abstract] [Full Text] [Related]

  • 15. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L, Turkson J, Karras JG, Jove R, Haura EB.
    Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138
    [Abstract] [Full Text] [Related]

  • 16. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP, Jiang GC, Yang F, Zhou ZL, Wang J.
    Zhonghua Wai Ke Za Zhi; 2007 Sep 15; 45(18):1267-70. PubMed ID: 18067742
    [Abstract] [Full Text] [Related]

  • 17. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M, Kawakami K, Stepensky VA, Maki RA, Robin H, Muller W, Husain SR, Puri RK.
    Clin Cancer Res; 2002 Nov 15; 8(11):3503-11. PubMed ID: 12429641
    [Abstract] [Full Text] [Related]

  • 18. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR, Cai JM, Tang GS, Li BL, Gao F, Cui JG, Liu HC.
    Ai Zheng; 2007 Aug 15; 26(8):820-7. PubMed ID: 17697540
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H, Mayer CE, Setinek U, Attems J, Ovtcharov S, Mikula M, Mikulits W, Micksche M, Berger W.
    Mol Cancer Res; 2007 May 15; 5(5):509-20. PubMed ID: 17510316
    [Abstract] [Full Text] [Related]

  • 20. Effect of interleukin-6 on the growth of human lung cancer cell line.
    Fu J, Zheng J, Fang W, Wu B.
    Chin Med J (Engl); 1998 Mar 15; 111(3):265-8. PubMed ID: 10374431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.